Genetic analysis of the cystatin C gene in familial and sporadic ALS patients

Brain Res. 2006 Feb 16:1073-1074:20-4. doi: 10.1016/j.brainres.2005.12.046. Epub 2006 Jan 26.

Abstract

Bunina bodies, small eosinophilic intraneuronal inclusions, stain positive for cystatin C and are the only specific pathological hallmark of amyotrophic lateral sclerosis (ALS). We screened the cystatin C gene (CST3) for mutations in 57 sporadic ALS patients and 12 familial ALS cases that did not possess a SOD1 mutation. We detected the known polymorphism in exon 1, a G/A transition at +73, in both familial and sporadic ALS patients. However, the allelic and genotypic frequencies of the +73 G/A polymorphism did not differ between ALS patients and control samples. No other mutation was detected in the ALS patients. The results reported here indicate that there may not be a direct genetic link between cystatin C and ALS, and it may be that deficits occur in proteins that interact with cystatin C.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis / genetics*
  • Chi-Square Distribution
  • Cystatin C
  • Cystatins / genetics*
  • DNA Mutational Analysis / methods
  • Family Health*
  • Female
  • Genotype
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Mutation
  • Polymorphism, Genetic
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1

Substances

  • CST3 protein, human
  • Cystatin C
  • Cystatins
  • SOD1 protein, human
  • Superoxide Dismutase
  • Superoxide Dismutase-1